ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Herpes Treatment Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-29Y11094
Home | Market Reports | Health| Reproductive Health
Global Herpes Treatment Market Research Report 2022
BUY CHAPTERS

Global Herpes Treatment Market Research Report 2025

Code: QYRE-Auto-29Y11094
Report
September 2025
Pages:80
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Gilead
GlaxoSmithKline PLC
Merck
Novartis
Abbott
Mylan NV
Teva Pharmaceutical Industries
Vical Inc

Herpes Treatment Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Herpes Treatment Market

Herpes Treatment Market

The global market for Herpes Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Genital herpes is a common sexually transmitted disease. With the increase in population of various regions, there is also an increase in the rate of health issues around the world. As the rate of diseases grow, the treatment markets are also expected to grow substantially. With respect to sexually transmitted disease like genital herpes, its treatment market includes different drug types like Acyclovir, Valacyclovir and Famciclovir. The indication of genital herpes include HSV-1 and HSV-2.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Herpes Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Herpes Treatment.
The Herpes Treatment market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Herpes Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Herpes Treatment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Herpes Treatment Market Report

Report Metric Details
Report Name Herpes Treatment Market
CAGR 5%
Segment by Type
  • Acyclovir
  • Valacyclovir
  • Famciclovir
Segment by Application
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Drug Stores
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Gilead, GlaxoSmithKline, Merck, Novartis, Abbott, Mylan, Teva Pharmaceutical Industries, Vical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Herpes Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Herpes Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Herpes Treatment Market report?

Ans: The main players in the Herpes Treatment Market are Gilead, GlaxoSmithKline, Merck, Novartis, Abbott, Mylan, Teva Pharmaceutical Industries, Vical

What are the Application segmentation covered in the Herpes Treatment Market report?

Ans: The Applications covered in the Herpes Treatment Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Stores

What are the Type segmentation covered in the Herpes Treatment Market report?

Ans: The Types covered in the Herpes Treatment Market report are Acyclovir, Valacyclovir, Famciclovir

1 Herpes Treatment Market Overview
1.1 Product Definition
1.2 Herpes Treatment by Type
1.2.1 Global Herpes Treatment Market Value Comparison by Type (2024 VS 2031)
1.2.2 Acyclovir
1.2.3 Valacyclovir
1.2.4 Famciclovir
1.3 Herpes Treatment by Application
1.3.1 Global Herpes Treatment Market Value by Application (2024 VS 2031)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Drug Stores
1.4 Global Herpes Treatment Market Size Estimates and Forecasts
1.4.1 Global Herpes Treatment Revenue 2020-2031
1.4.2 Global Herpes Treatment Sales 2020-2031
1.4.3 Global Herpes Treatment Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Herpes Treatment Market Competition by Manufacturers
2.1 Global Herpes Treatment Sales Market Share by Manufacturers (2020-2025)
2.2 Global Herpes Treatment Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Herpes Treatment Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Herpes Treatment, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Herpes Treatment, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Herpes Treatment, Product Type & Application
2.7 Global Key Manufacturers of Herpes Treatment, Date of Enter into This Industry
2.8 Global Herpes Treatment Market Competitive Situation and Trends
2.8.1 Global Herpes Treatment Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Herpes Treatment Players Market Share by Revenue
2.8.3 Global Herpes Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Herpes Treatment Market Scenario by Region
3.1 Global Herpes Treatment Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Herpes Treatment Sales by Region: 2020-2031
3.2.1 Global Herpes Treatment Sales by Region: 2020-2025
3.2.2 Global Herpes Treatment Sales by Region: 2026-2031
3.3 Global Herpes Treatment Revenue by Region: 2020-2031
3.3.1 Global Herpes Treatment Revenue by Region: 2020-2025
3.3.2 Global Herpes Treatment Revenue by Region: 2026-2031
3.4 North America Herpes Treatment Market Facts & Figures by Country
3.4.1 North America Herpes Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Herpes Treatment Sales by Country (2020-2031)
3.4.3 North America Herpes Treatment Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Herpes Treatment Market Facts & Figures by Country
3.5.1 Europe Herpes Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Herpes Treatment Sales by Country (2020-2031)
3.5.3 Europe Herpes Treatment Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Herpes Treatment Market Facts & Figures by Region
3.6.1 Asia Pacific Herpes Treatment Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Herpes Treatment Sales by Region (2020-2031)
3.6.3 Asia Pacific Herpes Treatment Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Herpes Treatment Market Facts & Figures by Country
3.7.1 Latin America Herpes Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Herpes Treatment Sales by Country (2020-2031)
3.7.3 Latin America Herpes Treatment Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Herpes Treatment Market Facts & Figures by Country
3.8.1 Middle East and Africa Herpes Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Herpes Treatment Sales by Country (2020-2031)
3.8.3 Middle East and Africa Herpes Treatment Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Herpes Treatment Sales by Type (2020-2031)
4.1.1 Global Herpes Treatment Sales by Type (2020-2025)
4.1.2 Global Herpes Treatment Sales by Type (2026-2031)
4.1.3 Global Herpes Treatment Sales Market Share by Type (2020-2031)
4.2 Global Herpes Treatment Revenue by Type (2020-2031)
4.2.1 Global Herpes Treatment Revenue by Type (2020-2025)
4.2.2 Global Herpes Treatment Revenue by Type (2026-2031)
4.2.3 Global Herpes Treatment Revenue Market Share by Type (2020-2031)
4.3 Global Herpes Treatment Price by Type (2020-2031)
5 Segment by Application
5.1 Global Herpes Treatment Sales by Application (2020-2031)
5.1.1 Global Herpes Treatment Sales by Application (2020-2025)
5.1.2 Global Herpes Treatment Sales by Application (2026-2031)
5.1.3 Global Herpes Treatment Sales Market Share by Application (2020-2031)
5.2 Global Herpes Treatment Revenue by Application (2020-2031)
5.2.1 Global Herpes Treatment Revenue by Application (2020-2025)
5.2.2 Global Herpes Treatment Revenue by Application (2026-2031)
5.2.3 Global Herpes Treatment Revenue Market Share by Application (2020-2031)
5.3 Global Herpes Treatment Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Gilead
6.1.1 Gilead Company Information
6.1.2 Gilead Description and Business Overview
6.1.3 Gilead Herpes Treatment Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Gilead Herpes Treatment Product Portfolio
6.1.5 Gilead Recent Developments/Updates
6.2 GlaxoSmithKline
6.2.1 GlaxoSmithKline Company Information
6.2.2 GlaxoSmithKline Description and Business Overview
6.2.3 GlaxoSmithKline Herpes Treatment Sales, Revenue and Gross Margin (2020-2025)
6.2.4 GlaxoSmithKline Herpes Treatment Product Portfolio
6.2.5 GlaxoSmithKline Recent Developments/Updates
6.3 Merck
6.3.1 Merck Company Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Herpes Treatment Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Merck Herpes Treatment Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Company Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Herpes Treatment Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Novartis Herpes Treatment Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Abbott
6.5.1 Abbott Company Information
6.5.2 Abbott Description and Business Overview
6.5.3 Abbott Herpes Treatment Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Abbott Herpes Treatment Product Portfolio
6.5.5 Abbott Recent Developments/Updates
6.6 Mylan
6.6.1 Mylan Company Information
6.6.2 Mylan Description and Business Overview
6.6.3 Mylan Herpes Treatment Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Mylan Herpes Treatment Product Portfolio
6.6.5 Mylan Recent Developments/Updates
6.7 Teva Pharmaceutical Industries
6.7.1 Teva Pharmaceutical Industries Company Information
6.7.2 Teva Pharmaceutical Industries Description and Business Overview
6.7.3 Teva Pharmaceutical Industries Herpes Treatment Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Teva Pharmaceutical Industries Herpes Treatment Product Portfolio
6.7.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.8 Vical
6.8.1 Vical Company Information
6.8.2 Vical Description and Business Overview
6.8.3 Vical Herpes Treatment Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Vical Herpes Treatment Product Portfolio
6.8.5 Vical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Herpes Treatment Industry Chain Analysis
7.2 Herpes Treatment Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Herpes Treatment Production Mode & Process Analysis
7.4 Herpes Treatment Sales and Marketing
7.4.1 Herpes Treatment Sales Channels
7.4.2 Herpes Treatment Distributors
7.5 Herpes Treatment Customer Analysis
8 Herpes Treatment Market Dynamics
8.1 Herpes Treatment Industry Trends
8.2 Herpes Treatment Market Drivers
8.3 Herpes Treatment Market Challenges
8.4 Herpes Treatment Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Gilead
GlaxoSmithKline PLC
Merck
Novartis
Abbott
Mylan NV
Teva Pharmaceutical Industries
Vical Inc
List of Tables
 Table 1. Global Herpes Treatment Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Herpes Treatment Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Herpes Treatment Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Herpes Treatment Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Herpes Treatment Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Herpes Treatment Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Herpes Treatment Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Herpes Treatment Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Herpes Treatment, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Herpes Treatment, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Herpes Treatment, Product Type & Application
 Table 12. Global Key Manufacturers of Herpes Treatment, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Herpes Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Herpes Treatment as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Herpes Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Herpes Treatment Sales by Region (2020-2025) & (K Units)
 Table 18. Global Herpes Treatment Sales Market Share by Region (2020-2025)
 Table 19. Global Herpes Treatment Sales by Region (2026-2031) & (K Units)
 Table 20. Global Herpes Treatment Sales Market Share by Region (2026-2031)
 Table 21. Global Herpes Treatment Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Herpes Treatment Revenue Market Share by Region (2020-2025)
 Table 23. Global Herpes Treatment Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Herpes Treatment Revenue Market Share by Region (2026-2031)
 Table 25. North America Herpes Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Herpes Treatment Sales by Country (2020-2025) & (K Units)
 Table 27. North America Herpes Treatment Sales by Country (2026-2031) & (K Units)
 Table 28. North America Herpes Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Herpes Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Herpes Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Herpes Treatment Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Herpes Treatment Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Herpes Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Herpes Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Herpes Treatment Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Herpes Treatment Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Herpes Treatment Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Herpes Treatment Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Herpes Treatment Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Herpes Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Herpes Treatment Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Herpes Treatment Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Herpes Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Herpes Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Herpes Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Herpes Treatment Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Herpes Treatment Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Herpes Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Herpes Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Herpes Treatment Sales (K Units) by Type (2020-2025)
 Table 51. Global Herpes Treatment Sales (K Units) by Type (2026-2031)
 Table 52. Global Herpes Treatment Sales Market Share by Type (2020-2025)
 Table 53. Global Herpes Treatment Sales Market Share by Type (2026-2031)
 Table 54. Global Herpes Treatment Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Herpes Treatment Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Herpes Treatment Revenue Market Share by Type (2020-2025)
 Table 57. Global Herpes Treatment Revenue Market Share by Type (2026-2031)
 Table 58. Global Herpes Treatment Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Herpes Treatment Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Herpes Treatment Sales (K Units) by Application (2020-2025)
 Table 61. Global Herpes Treatment Sales (K Units) by Application (2026-2031)
 Table 62. Global Herpes Treatment Sales Market Share by Application (2020-2025)
 Table 63. Global Herpes Treatment Sales Market Share by Application (2026-2031)
 Table 64. Global Herpes Treatment Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Herpes Treatment Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Herpes Treatment Revenue Market Share by Application (2020-2025)
 Table 67. Global Herpes Treatment Revenue Market Share by Application (2026-2031)
 Table 68. Global Herpes Treatment Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Herpes Treatment Price (USD/Unit) by Application (2026-2031)
 Table 70. Gilead Company Information
 Table 71. Gilead Description and Business Overview
 Table 72. Gilead Herpes Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Gilead Herpes Treatment Product
 Table 74. Gilead Recent Developments/Updates
 Table 75. GlaxoSmithKline Company Information
 Table 76. GlaxoSmithKline Description and Business Overview
 Table 77. GlaxoSmithKline Herpes Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. GlaxoSmithKline Herpes Treatment Product
 Table 79. GlaxoSmithKline Recent Developments/Updates
 Table 80. Merck Company Information
 Table 81. Merck Description and Business Overview
 Table 82. Merck Herpes Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Merck Herpes Treatment Product
 Table 84. Merck Recent Developments/Updates
 Table 85. Novartis Company Information
 Table 86. Novartis Description and Business Overview
 Table 87. Novartis Herpes Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Novartis Herpes Treatment Product
 Table 89. Novartis Recent Developments/Updates
 Table 90. Abbott Company Information
 Table 91. Abbott Description and Business Overview
 Table 92. Abbott Herpes Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Abbott Herpes Treatment Product
 Table 94. Abbott Recent Developments/Updates
 Table 95. Mylan Company Information
 Table 96. Mylan Description and Business Overview
 Table 97. Mylan Herpes Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Mylan Herpes Treatment Product
 Table 99. Mylan Recent Developments/Updates
 Table 100. Teva Pharmaceutical Industries Company Information
 Table 101. Teva Pharmaceutical Industries Description and Business Overview
 Table 102. Teva Pharmaceutical Industries Herpes Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Teva Pharmaceutical Industries Herpes Treatment Product
 Table 104. Teva Pharmaceutical Industries Recent Developments/Updates
 Table 105. Vical Company Information
 Table 106. Vical Description and Business Overview
 Table 107. Vical Herpes Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Vical Herpes Treatment Product
 Table 109. Vical Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Herpes Treatment Distributors List
 Table 113. Herpes Treatment Customers List
 Table 114. Herpes Treatment Market Trends
 Table 115. Herpes Treatment Market Drivers
 Table 116. Herpes Treatment Market Challenges
 Table 117. Herpes Treatment Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Herpes Treatment
 Figure 2. Global Herpes Treatment Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Herpes Treatment Market Share by Type: 2024 & 2031
 Figure 4. Acyclovir Product Picture
 Figure 5. Valacyclovir Product Picture
 Figure 6. Famciclovir Product Picture
 Figure 7. Global Herpes Treatment Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Herpes Treatment Market Share by Application: 2024 & 2031
 Figure 9. Hospital Pharmacies
 Figure 10. Retail Pharmacies
 Figure 11. Online Pharmacies
 Figure 12. Drug Stores
 Figure 13. Global Herpes Treatment Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Herpes Treatment Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Herpes Treatment Sales (2020-2031) & (K Units)
 Figure 16. Global Herpes Treatment Average Price (USD/Unit) & (2020-2031)
 Figure 17. Herpes Treatment Report Years Considered
 Figure 18. Herpes Treatment Sales Share by Manufacturers in 2024
 Figure 19. Global Herpes Treatment Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Herpes Treatment Players: Market Share by Revenue in Herpes Treatment in 2024
 Figure 21. Herpes Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Herpes Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Herpes Treatment Sales Market Share by Country (2020-2031)
 Figure 24. North America Herpes Treatment Revenue Market Share by Country (2020-2031)
 Figure 25. U.S. Herpes Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Herpes Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Herpes Treatment Sales Market Share by Country (2020-2031)
 Figure 28. Europe Herpes Treatment Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Herpes Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Herpes Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Herpes Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Herpes Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Herpes Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Herpes Treatment Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Herpes Treatment Revenue Market Share by Region (2020-2031)
 Figure 36. China Herpes Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Herpes Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Herpes Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Herpes Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Herpes Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Taiwan Herpes Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Herpes Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Herpes Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Herpes Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Philippines Herpes Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Latin America Herpes Treatment Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Herpes Treatment Revenue Market Share by Country (2020-2031)
 Figure 48. Mexico Herpes Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Brazil Herpes Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Argentina Herpes Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa Herpes Treatment Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Herpes Treatment Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey Herpes Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia Herpes Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. U.A.E Herpes Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of Herpes Treatment by Type (2020-2031)
 Figure 57. Global Revenue Market Share of Herpes Treatment by Type (2020-2031)
 Figure 58. Global Herpes Treatment Price (USD/Unit) by Type (2020-2031)
 Figure 59. Global Sales Market Share of Herpes Treatment by Application (2020-2031)
 Figure 60. Global Revenue Market Share of Herpes Treatment by Application (2020-2031)
 Figure 61. Global Herpes Treatment Price (USD/Unit) by Application (2020-2031)
 Figure 62. Herpes Treatment Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions